title: Targeting angiogenesis for treatment of human cancer.
abstract: Recent advances in cancer research highlighted the importance of target-specific drug discovery. In view of these advances, the most important mechanism in tumour growth is its ability to stimulate the formation of blood capillaries around itself called tumour-driven angiogenesis. Hence targeting the angiogenesis, inhibits the growth of blood vessels around it and responsible for death of the tumour due to starvation and accumulation of toxic waste. The therapy, thus, indirectly cytotoxic to the tumour cells by targeting newly developing blood vessels. In this review, we summarised the various antiangiogenic agents with their clinical uses and current status.
authors.affiliation: Department of Pharmaceutical Chemistry, VES's College of Pharmacy, Chembur, Mumbai-400 074, India.
authors.forename: R R
authors.initials: RR
authors.lastname: Somani
authors.forename: U V
authors.initials: UV
authors.lastname: Bhanushali
keywords: Angiogenesis; cancer; inhibitors of angiogenesis; small molecules
references.citation: Clin Cancer Res. 1999 Jul;5(7):1905-17
references.pmid: 10430098
references.citation: Oncologist. 2005 Aug;10(7):461-6
references.pmid: 16079312
references.citation: Clin Cancer Res. 2007 Aug 15;13(16):4664-6
references.pmid: 17699842
references.citation: J Periodontal Res. 1984 Nov;19(6):651-5
references.pmid: 6098638
references.citation: Oncologist. 2009 Jan;14(1):95-100
references.pmid: 19144678
references.citation: Oncogene. 1998 May 7;16(18):2419-23
references.pmid: 9620561
references.citation: Invest New Drugs. 2007 Apr;25(2):165-72
references.pmid: 16983506
references.citation: Carcinogenesis. 1997 Nov;18(11):2093-100
references.pmid: 9395207
references.citation: Br J Cancer. 1999 Feb;79(3-4):509-14
references.pmid: 10027321
references.citation: J Clin Pharm Ther. 2007 Feb;32(1):1-14
references.pmid: 17286784
references.citation: J Med Chem. 1999 Dec 30;42(26):5369-89
references.pmid: 10639280
references.citation: Cancer Res. 2006 Sep 1;66(17):8715-21
references.pmid: 16951187
references.citation: Eur J Biochem. 1997 Jul 1;247(1):356-63
references.pmid: 9249047
references.citation: Clin Cancer Res. 2007 Mar 1;13(5):1367-73
references.pmid: 17332278
references.citation: N Engl J Med. 2004 Jun 3;350(23):2335-42
references.pmid: 15175435
references.citation: Invest New Drugs. 2007 Aug;25(4):359-67
references.pmid: 17237909
references.citation: Bioorg Med Chem Lett. 2001 Jul 23;11(14):1911-4
references.pmid: 11459659
references.citation: Nat Rev Drug Discov. 2007 May;6(5):349-56
references.pmid: 17431406
references.citation: Mol Cancer Ther. 2006 Apr;5(4):995-1006
references.pmid: 16648571
references.citation: Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4421s-4425s
references.pmid: 16857821
references.citation: Adv Dent Res. 1998 Nov;12(2):12-26
references.pmid: 9972117
references.citation: J Natl Cancer Inst. 2001 Feb 7;93(3):178-93
references.pmid: 11158186
references.citation: N Engl J Med. 2007 Nov 15;357(20):2040-8
references.pmid: 18003960
references.citation: Oncologist. 2007 May;12(5):577-83
references.pmid: 17522246
references.citation: Oncologist. 2001;6(5):415-27
references.pmid: 11675519
references.citation: J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
references.pmid: 1688381
references.citation: Ann N Y Acad Sci. 1999 Jun 30;878:236-70
references.pmid: 10415735
references.citation: Oncologist. 2007 Apr;12(4):443-50
references.pmid: 17470687
references.citation: J Med Chem. 2000 Jun 15;43(12):2310-23
references.pmid: 10882357
references.citation: Br J Clin Pharmacol. 1998 Jan;45(1):21-6
references.pmid: 9489589
references.citation: N Engl J Med. 1971 Nov 18;285(21):1182-6
references.pmid: 4938153
references.citation: JAMA. 2006 Jun 7;295(21):2516-24
references.pmid: 16757724
references.citation: Biochem Pharmacol. 2001 Feb 1;61(3):253-70
references.pmid: 11172729
references.citation: Cancer Chemother Pharmacol. 1995;36(5):418-24
references.pmid: 7543375
references.citation: Oncologist. 2009 Apr;14(4):378-90
references.pmid: 19349511
references.citation: Clin Cancer Res. 2003 May;9(5):1648-55
references.pmid: 12738717
references.citation: Curr Opin Periodontol. 1996;3:85-96
references.pmid: 8624573
references.citation: Oncologist. 2003;8(4):303-6
references.pmid: 12897327
references.citation: Nature. 2005 Dec 15;438(7070):967-74
references.pmid: 16355214
references.citation: J Clin Oncol. 2005 Feb 1;23(4):842-9
references.pmid: 15681529
references.citation: Clin Cancer Res. 2006 Mar 1;12(5):1556-63
references.pmid: 16533781
references.citation: Methods Enzymol. 2006;407:597-612
references.pmid: 16757355